Compliance With LDL-Lowering Therapy (Study P05467)(COMPLETED)

Organon

Status: Completed

Conditions: Hyperlipidemia; Coronary Heart Disease; Hypercholesterolemia

Treatments: Drug: Statin

Study type: Observational

Funder types: Industry

Identifiers

NCT00723723

P05467

Details and patient eligibility

About

This observational study is being conducted in patients receiving statin treatment as secondary prevention of coronary heart disease under the current standard of care in compliance with European guidelines. The purpose of the study is to evaluate the percentage of these patients that reach target LDL levels. Additionally this study will measure the patient's compliance to treatment as assessed by counting the returned tablets. Both assessments will be made at visits conducted 6-8 weeks after the first visit and 28-32 weeks after the first visit.

Enrollment: 555 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• willingness to participate in the study
• 18 years of age or more
• clinically established cardiovascular disease to be considered as patients in secondary prevention
• prior therapy with any statin without achieving goal (2.5 mmol/L of LDL cholesterol) at last lipid check performed

Exclusion criteria

• None

Trial design

555 participants in 1 patient group

Patients with coronary heart disease

Description:

Patients being treated with a statin for secondary prevention of coronary heart disease

Treatment:

Drug: Statin